Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) ROA

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roa for the quarter ending 2026-06-27 was -3.14%, a change of -2.28% year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roa for the quarter ending 2026-03-28 was -2.37%, a change of -2.06% year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roa for the quarter ending 2025-12-27 was -1.99%, a 693.06% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roa for the quarter ending 2025-09-27 was -1.06%, a 119.82% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roa for fiscal 2025 was -1.99%, a 693.06% decline from fiscal 2024.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roa for fiscal 2024 was 0.34%, a 94.27% decline from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roa for fiscal 2023 was 5.86%, a 9.53% decline from fiscal 2022.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roa for fiscal 2022 was 6.48%, a 14.11% increase from fiscal 2021.
Available history
2009-12-26 to 2026-06-27
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-27-3.14%-$236.3M-$1.48M$7.53B
2026-03-28-2.37%-$182.84M-$14.84M$7.73B
2025-12-27-1.99%-$142.16M-$276.56M$7.14B
2025-09-27-1.06%-$79.62M$54.42M$7.51B
2025-06-28-0.86%-$64.88M$52.33M$7.56B
2025-03-29-0.31%-$23.31M$25.47M$7.58B
2024-12-280.34%$25.29M-$214.50M$7.53B
2024-09-285.35%$427.99M$69.66M$8B
2024-06-295.61%$445.72M$94.08M$7.95B
2024-03-305.53%$450.9M$72.96M$8.15B
2023-12-305.86%$480.37M$187.08M$8.2B
2023-09-306.32%$480.52M$87.39M$7.61B
2023-07-016.31%$490.12M$97.02M$7.77B
2023-04-016.51%$501.34M$103.13M$7.7B
2022-12-316.48%$492.61M$187.41M$7.6B
2022-09-246.00%$443.33M$96.47M$7.38B
2022-06-255.99%$450.88M$109.32M$7.53B
2022-03-266.08%$430.13M$93.02M$7.08B
2021-12-255.68%$398.84M$137.58M$7.02B
2021-09-255.71%$403.2M$103.43M$7.06B
2021-06-265.96%$400.65M$88.45M$6.72B
2021-03-276.51%$378.4M$61.53M$5.81B
2020-12-266.65%$365.31M$143.19M$5.49B
2020-09-265.79%$301.63M$102.91M$5.21B
2020-06-275.20%$272.57M$67.44M$5.24B
2020-03-284.79%$249.21M$50.77M$5.2B
2019-12-285.41%$254.06M$80.35M$4.69B
2019-09-285.10%$233.75M$72.81M$4.58B
2019-06-294.78%$221.1M$43.73M$4.63B
2019-03-305.89%$231.17M$55.13M$3.93B
2018-12-295.93%$228.72M$59.66M$3.86B
2018-09-293.67%$139.46M$60.37M$3.8B
2018-06-303.40%$131.51M$53.71M$3.87B
2018-03-314.39%$131.74M$52.63M$3B
2017-12-304.28%$125.45M-$29.85M$2.93B
2017-09-306.97%$199.74M$52.47M$2.87B
2017-07-016.66%$184.82M$53.95M$2.77B
2017-04-016.15%$165.78M$46.78M$2.7B
2016-12-315.77%$156.37M$44.68M$2.71B
2016-09-245.33%$143.5M$37.73M$2.69B
2016-06-255.19%$143.33M$35.21M$2.76B
2016-03-267.46%$157.02M$37.14M$2.1B
2015-12-267.30%$151.09M$31.88M$2.07B
2015-09-267.20%$146.4M$37.38M$2.03B
2015-06-277.47%$140.88M$48.51M$1.89B
2015-03-286.90%$127.45M$31.54M$1.85B
2014-12-276.85%$128.2M$27.17M$1.87B
2014-09-276.51%$119.97M$32.04M$1.84B
2014-06-286.38%$118.84M$35.26M$1.86B
2014-03-296.70%$110.74M$32.23M$1.65B
2013-12-286.38%$104.15M$19.10M$1.63B
2013-09-286.28%$103.24M$30.87M$1.64B
2013-06-295.81%$94.21M$27.28M$1.62B
2013-03-306.05%$97.09M$25.58M$1.6B
2012-12-296.17%$97.87M$18.42M$1.59B
2012-09-296.80%$106.57M$21.97M$1.57B
2012-06-306.68%$103.26M$30.47M$1.55B
2012-03-316.76%$105.09M$26.44M$1.56B
2011-12-317.06%$109.98M$27.11M$1.56B
2011-09-24-16.73%-$265.23M$18.80M$1.59B
2011-06-25-18.14%-$309.36M$32.32M$1.71B
2011-03-26-18.78%-$327.69M$31.34M$1.74B
2010-12-25-19.74%-$342.12M-$343.56M$1.73B
2010-09-251.10%$22.95M-$24.94M$2.08B
2010-06-263.95%$85.17M$14.45M$2.16B

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-27-1.99%-$142.16M$7.14B
2024-12-280.34%$25.29M$7.53B
2023-12-305.86%$480.37M$8.2B
2022-12-316.48%$492.61M$7.6B
2021-12-255.68%$398.84M$7.02B
2020-12-266.65%$365.31M$5.49B
2019-12-285.41%$254.06M$4.69B
2018-12-295.93%$228.72M$3.86B
2017-12-304.28%$125.45M$2.93B
2016-12-315.77%$156.37M$2.71B
2015-12-267.30%$151.09M$2.07B
2014-12-276.85%$128.2M$1.87B
2013-12-286.38%$104.15M$1.63B
2012-12-296.17%$97.87M$1.59B
2011-12-317.06%$109.98M$1.56B
2010-12-25-19.74%-$342.12M$1.73B
2009-12-265.11%$112.6M$2.2B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71